Public, NASDAQ:IDIX
NASDAQ Global Market
Premium Company Profile - Idenix Pharmaceuticals, Inc. - New Research Report on Companies and Markets
Date: Wed, 02 Jul 2008 14:12:26 GMT
Tags:
Premium Company Profile - Idenix Pharmaceuticals, Inc. - New Research Report on Companies and Markets
PR-Inside.com (Pressemitteilung) - Jul 2, 2008
PR-Inside.com (Pressemitteilung) - Jul 2, 2008
Idenix Pharmaceuticals develops drugs for the treatment of human viral and other infectious diseases.Novartis is the major shareholder of the company owning 56 % of Idenix and has development ...
SmallCapStockAnalyst.com Reports Bancroft Uranium Inc. (OTCBB: BCFT) Announces Final Series of Drilling Results at Monmouth Uranium Project
Date: Mon, 16 Jun 2008 07:22:04 GMT
Tags:
SmallCapStockAnalyst.com Reports Bancroft Uranium Inc. (OTCBB: BCFT) Announces Final Series of Drilling Results at Monmouth Uranium Project
Emailwire - Jun 16, 2008
Emailwire - Jun 16, 2008
Active Stocks to Watch : Bancroft Uranium Inc ( OTC BB : BCFT ) , Douglas Lake Minerals ( OTC BB : DLKM ) , Idenix Pharmaceuticals , Inc . ( NASDAQ : IDIX ) , Transmeridian Exploration , Inc ...
Idenix HIV treatment shows "potent antiviral activity"
Date: Fri, 13 Jun 2008 11:46:10 GMT
Tags:
Idenix HIV treatment shows "potent antiviral activity"
Phoenix Business Journal (subscription) - Jun 13, 2008
Phoenix Business Journal (subscription) - Jun 13, 2008
Idenix Pharmaceuticals Inc . said it has generated positive clinical trial data from a possible new HIV treatment.The Cambridge , Mass . - based company ( Nasdaq : IDIX ) said Thursday that its ...
Idenix Pharma says its drug candidate IDX899 shows potent antiviral activity, safety profile in HIV patients - Update
Date: Thu, 12 Jun 2008 16:01:45 GMT
Tags:
Idenix Pharma says its drug candidate IDX899 shows potent antiviral activity, safety profile in HIV patients - Update
RTT News - Jun 12, 2008
Idenix Pharma reports positive Phase I/II data of IDX899 to treat HIV-1 - Trading Markets (press release)
RTT News - Jun 12, 2008
( RTTNews ) - Thursday , Idenix Pharmaceuticals Inc . ( IDIX : News , Chart , Quote ) announced that IDX899 in Phase I / II trial confirmed potent antiviral activity and favorable safety profile ...
Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infected Patients - Biloxi Sun HeraldIdenix Pharma reports positive Phase I/II data of IDX899 to treat HIV-1 - Trading Markets (press release)
BUYINS.NET: AAI, EXM, TRX, ACUS, HDSN, IDIX Have Been Removed From Naked Short List Today
Date: Thu, 12 Jun 2008 15:25:34 GMT
Tags:
BUYINS.NET: AAI, EXM, TRX, ACUS, HDSN, IDIX Have Been Removed From Naked Short List Today
Trading Markets (press release) - Jun 12, 2008
Trading Markets (press release) - Jun 12, 2008
ively.After the SEC passed Regulation SHO , exchanges were forced to allow data processors like Buyins . net to access the data.The SqueezeTrigger database collects individual short trade data ...
Idenix HIV treatment shows "potent antiviral activity" (at bizjournals.com)
Date: Thu, 12 Jun 2008 14:15:20 Etc/GMT
Tags:
Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infected Patients (PR Newswire)
Date: Thu, 12 Jun 2008 12:00:00 Etc/GMT
Tags:
Idenix Pharmaceuticals, Inc. , a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today reported phase I/II data for IDX899, a non-nucleoside reverse transcriptase inhibitor being developed for the treatment of HIV-1.
Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference (PR Newswire)
Date: Wed, 4 Jun 2008 13:00:00 Etc/GMT
Tags:
Idenix Pharmaceuticals, Inc. announced today that Idenix management will present a corporate overview at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference on Thursday, June 12, 2008 at 3:30 pm.
IDENIX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)
Date: Thu, 15 May 2008 14:58:54 Etc/GMT
Tags:
Idenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference (PR Newswire)
Date: Mon, 12 May 2008 20:00:00 Etc/GMT
Tags:
Idenix Pharmaceuticals, Inc. announced today that Idenix management will present a corporate overview at the Rodman & Renshaw 5th Annual Global Healthcare Conference on Tuesday, May 20, 2008 at 12:00 p.m.